Latest Articles

Publication Date
All News Scientific
NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData - Express Pharma

NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData Express Pharma

Published: March 20, 2025, 8:30 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - The Malaysian Reserve

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy The Malaysian …

Published: March 19, 2025, 10:53 p.m.
Read Full Article
ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide - ACCESS Newswire

ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide ACCESS Newswire

Published: March 19, 2025, 12:02 p.m.
Read Full Article
NHS approval of endometriosis therapy Ryeqo enhances patient care - The Hippocratic Post

NHS approval of endometriosis therapy Ryeqo enhances patient care The Hippocratic Post

Published: March 19, 2025, 12:01 p.m.
Read Full Article
ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide - Newswire

ESSE Care Aims to Transform Endometriosis Care by Launching a Year-Long Initiative That Brings Together Patients and Experts Worldwide Newswire

Published: March 19, 2025, noon
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Weekly Voice

Published: March 19, 2025, 11:20 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Canada Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Canada …

Published: March 19, 2025, 11 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Finance

Published: March 19, 2025, 11 a.m.
Read Full Article
Ireland's healthcare system doesn't listen to endometriosis patients - Irish Examiner

Ireland's healthcare system doesn't listen to endometriosis patients Irish Examiner

Published: March 18, 2025, 12:54 a.m.
Read Full Article
I see a lot of patients who’ve been wrongly diagnosed with IBS - Gold Coast Bulletin

I see a lot of patients who’ve been wrongly diagnosed with IBS Gold Coast Bulletin

Published: March 17, 2025, 6:05 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!